Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Beauty Health (SKIN) over the last 5 years, with Q3 2025 value amounting to $601000.0.

  • Beauty Health's Non Operating Income rose 77101.45% to $601000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $18.9 million, marking a year-over-year decrease of 4332.29%. This contributed to the annual value of $33.6 million for FY2024, which is 54544.23% up from last year.
  • According to the latest figures from Q3 2025, Beauty Health's Non Operating Income is $601000.0, which was up 77101.45% from $18.1 million recorded in Q2 2025.
  • Beauty Health's 5-year Non Operating Income high stood at $327.2 million for Q4 2021, and its period low was -$210.8 million during Q3 2021.
  • Over the past 5 years, Beauty Health's median Non Operating Income value was $88000.0 (recorded in 2024), while the average stood at $3.8 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 10655.92% in 2022, then skyrocketed by 3674893.62% in 2024.
  • Quarter analysis of 5 years shows Beauty Health's Non Operating Income stood at $327.2 million in 2021, then crashed by 100.39% to -$1.3 million in 2022, then surged by 89.21% to -$137000.0 in 2023, then soared by 164.23% to $88000.0 in 2024, then surged by 582.95% to $601000.0 in 2025.
  • Its Non Operating Income stands at $601000.0 for Q3 2025, versus $18.1 million for Q2 2025 and $60000.0 for Q1 2025.